未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
First-line (1L) osimertinib (osi) ± platinum-pemetrexed chemotherapy (CTx) for EGFR-mutated (EGFRm) advanced non-small cell lung cancer (NSCLC): FLAURA2 Asian cohort 一线（1L）奥希替尼（osi）± 铂类培美曲塞化疗（CTx）用于EGFR突变（EGFRm）晚期非小细胞肺癌（NSCLC）：FLAURA2亚洲队列 Yang, J. C-H.; Kobayashi, K.; Chewaskulyong, B.; Tran, T. V.; Biswas, B.; Lee, K. H.; Feng, P-H.; Pham, X. D.; Yao, Y.; Kuyama, S.; Bing, J. Y. Tan Chun; Bhise, R.; Ahn, M-J.; Sriuranpong, V.; Li, R. K.; Monterroso, E. Armenteros; Barrett, K.; Albayaty, M.; Cheng, Y. 分享 收藏
A randomized controlled trial to relieve distress of chemotherapy-induced peripheral neuropathy by magnetic field: SMILE study 一项通过磁场缓解化疗诱导性周围神经病变痛苦的临床随机对照试验：SMILE研究 Kubo, E.; Satomi, E.; Mukohara, T.; Fuse, N.; Wakabayashi, M.; Tsukada, Y.; Ishiki, H.; Takayama, S.; Kanemitsu, Y.; Kishita, I.; Kobayashi, K.; Kurihara, C.; Hirano, N.; Ikeno, T.; Miura, T.; Sato, A. 分享 收藏
Clinical significance of visual cardiac 18F-FDG uptake in advanced non-small cell lung cancer Hashimoto, Kosuke; Kaira, Kyoichi; Imai, Hisao; Yamaguchi, Ou; Mouri, Atsuto; Shiono, Ayako; Miura, Yu; Kobayashi, Kunihiko; Kagamu, Hiroshi; Kuji, Ichiei 分享 收藏
Importance of subpleural fibrosis measured by a computer-aided system in patients with interstitial pneumonias, the prospective multicenter study Iwasawa, Tae; Okuda, Ryo; Johkoh, Takeshi; Sakai, Fumikazu; Fujimoto, Kiminori; Sumikawa, Hiromitsu; Egashira, Ryoko; Arai, Toru; Kondoh, Yasuhiro; Nakamura, Yutaro; Miyamoto, Atsushi; Tomii, Keisuke; Suda, Takafumi; Hebisawa, Akira; Handa, Tomohiro; Wasamoto, Satoshi; Inoue, Hiromasa; Narumoto, Osamu; Morita, Masato; Gon, Yasuhiro; Fujita, Masaki; Tasaka, Sadatomo; Takamatsu, Kazufumi; Ito, Hiroyuki; Baba, Tomohisa; Nukiwa, Toshihiro; Kobayashi, Kunihiko; Ogura, Takashi 分享 收藏
Effect of telomere length and TERT/TERC rare variants on survival in Japanese patients with idiopathic interstitial pneumonias :Genetic predisposition study from the Japanese Idiopathic Interstitial Pneumonias (JIPS) Registry (NEJ036A) Hisata, Shu; Tanino, Yoshinori; Okuda, Ryo; Ogura, Takashi; Isshiki, Takuma; Horimasu, Yasushi; Hamada, Naoki; Arai, Naoki; Tsubata, Yukari; Suda, Takafumi; Horio, Yukihiro; Ishikawa, Nobuhisa; Kondoh, Yasuhiro; Toyoshima, Mikio; Ishii, Haruyuki; Abe, Mitsuhiro; Kato, Motoyasu; Tanigawa, Motoaki; Tomioka, Hiromi; Chiba, Hirofumi; Arai, Toru; Nishioka, Yasuhiko; Hattori, Noboru; Hoshino, Tomoaki; Shimizu, Yasuo; Sakamoto, Koji; Ishikawa, Shizukiyo; Mieno, Makiko Naka; Baba, Tomohisa; Miyazaki, Yasunari; Nukiwa, Toshihiro; Kobayashi, Kunihiko; Suzuki, Takuji; Hagiwara, Koichi 分享 收藏
Impact of Cachexia and First-Line Systemic Therapy for Previously Untreated Advanced Non-Small Cell Lung Cancer: NEJ050A 恶病质和一线全身治疗对未经治疗的晚期非小细胞肺癌的影响: NEJ050A Miura, Keita; Shukuya, Takehito; Furuya, Naoki; Morita, Ryo; Kisohara, Akira; Mouri, Atsuto; Watanabe, Satoshi; Tanaka, Hisashi; Hirata, Aya; Hakozaki, Taiki; Hamai, Kosuke; Matsumoto, Naoko; Watanabe, Kana; Ashinuma, Hironori; Miyauchi, Eisaku; Sugano, Koji; Hosokawa, Shinobu; Amano, Koji; Morita, Satoshi; Kobayashi, Kunihiko; Maemonodo, Makoto; Takahashi, Kazuhisa 分享 收藏
A phase II study of daily carboplatin plus irradiation followed by durvalumab therapy for older adults (≥75 years) with unresectable III non-small-cell lung cancer and performance status of 2: NEJ039A Mouri, A.; Kisohara, A.; Morita, R.; Ko, R.; Nakagawa, T.; Makiguchi, T.; Isobe, K.; Ishikawa, N.; Kondo, T.; Akiyama, M.; Bessho, A.; Honda, R.; Yoshimura, K.; Kagamu, H.; Kato, S.; Kobayashi, K.; Kaira, K.; Maemondo, M. 分享 收藏
Lung immune prognostic index (LIPI) as a guide for addition of chemotherapy in immunotherapy in elderly patients (Pts) with non-small cell lung cancer (NSCLC): NEJ057 肺癌免疫预后指数（LIPI）作为指导老年非小细胞肺癌（NSCLC）患者（Pts）在免疫治疗中添加化疗的依据：NEJ057 Honjo, O.; Tozuka, T.; Tsukita, Y.; Kushiro, K.; Hosokawa, S.; Uematsu, M.; Sumi, T.; Naito, T.; Ito, K.; Wakui, H.; Obata, H.; Inoue, T.; Kamimura, M.; Tsubata, Y.; Jingu, D.; Sato, M.; Miyauchi, E.; Morita, S.; Kobayashi, K.; Asahina, H. 分享 收藏
FLAURA2: exploratory analysis of baseline (BL) and on-treatment plasma EGFRm dynamics in patients (pts) with EGFRm advanced NSCLC treated with first-line (1L) osimertinib (osi) ± platinum-pemetrexed Janne, Pasi A.; Kobayashi, Kunihiko; Robichaux, Jacqulyne; Lee, Chee Khoon; Sugawara, Shunichi; Yang, Tsung-Ying; Kim, Tae Min; Yanagitani, Noriko; Kim, Sang-We; Markovets, Aleksandra; Bhetariya, Preetida; Poole, Lynne; Ghiorghiu, Dana; Hartmaier, Ryan; Yang, James Chih-Hsin; Planchard, David 分享 收藏
Immunotherapy With Radiotherapy for Brain Metastases in Patients With NSCLC: NEJ060 NSCLC患者脑转移瘤放疗免疫治疗: NEJ060 Tozuka, Takehiro; Minegishi, Yuji; Yamaguchi, Ou; Watanabe, Kana; Toi, Yukihiro; Saito, Ryota; Nagai, Yoshiaki; Tamura, Yosuke; Shoji, Tetsuaki; Odagiri, Haruka; Ebi, Noriyuki; Sakai, Kosuke; Kanaji, Nobuhiro; Izumi, Makoto; Soda, Sayo; Watanabe, Satoshi; Morita, Satoshi; Kobayashi, Kunihiko; Seike, Mashiro 分享 收藏
A phase II study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study) Watanabe, Satoshi; Furuya, Naoki; Nakamura, Atsushi; Shiihara, Jun; Nakachi, Ichiro; Tanaka, Hisashi; Nakao, Mika; Minato, Koichi; Seike, Masahiro; Sasaki, Shinichi; Kisohara, Akira; Takeuchi, Susumu; Honda, Ryoichi; Takamura, Kei; Kagamu, Hiroshi; Yoshimura, Kenichi; Kobayashi, Kunihiko; Kikuchi, Toshiaki 分享 收藏
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC 奥希替尼联合或不联合化疗治疗EGFR突变的晚期NSCLC Planchard, D.; Janne, P. A.; Cheng, Y.; Yang, J. C. -H.; Yanagitani, N.; Kim, S-W; Sugawara, S.; Yu, Y.; Fan, Y.; Geater, S. L.; Laktionov, K.; Lee, C. K.; Valdiviezo, N.; Ahmed, S.; Maurel, J-M; Andrasina, I; Goldman, J.; Ghiorghiu, D.; Rukazenkov, Y.; Todd, A.; Kobayashi, K. 分享 收藏
Efficacy of whole brain radiotherapy for patients with leptomeningeal metastasis of non-small cell lung cancer: NEJ049 Furuta, Megumi; Miyauchi, Eisaku; Suzuki, Aya; Ashinuma, Hironori; Arai, Daisuke; Shimonishi, Atushi; Hosokawa, Shinobu; Hotta, Takamasa; Inomata, Minehiko; Morita, Satoshi; Ko, Ryo; Okuma, Yusuke; Sasaki, Takaaki; Kaira, Kyoichi; Kobayashi, Kunihiko; Sugiura, Hisatoshi 分享 收藏
First-line (1L) osimertinib plus platinum-pemetrexed in EGFRmutated (EGFRm) advanced NSCLC: Updated FLAURA2 safety run-in (SRI) results Planchard, D.; Poltoratskiy, A.; Kim, S-W.; Kim, T. M.; Yanagitani, N.; Kagamu, H.; Feng, P-H.; Hughes, B.; Yang, T-Y.; Yang, J. C-H.; Lee, C. K.; Karaseva, N.; Mitchell, P.; Tambo, Y.; Monterroso, E. Armenteros; Todd, A.; Sahasrabudhe, A.; Janne, P. A.; Kobayashi, K. 分享 收藏
Acquired mechanisms of resistance to first-line (1L) osimertinib with or without platinum-based chemotherapy (CT) in EGFR-mutated (EGFRm) advanced NSCLC: Preliminary data from FLAURA2 Lee, C. K.; Robichaux, J. P.; Janne, P. A.; Kim, S-W.; Kim, T. M.; Kobayashi, K.; Planchard, D.; Sugawara, S.; Yanagitani, N.; Yang, T-Y.; Markovets, A.; Bhetaryia, P.; Poole, L.; Rukazenkov, Y.; Hartmaier, R. J.; Yang, J. C-H. 分享 收藏
A phase II study of daily carboplatin plus irradiation followed by durvalumab for unresectable III non-small cell lung cancer patients with PS 2 or elderly (S75 years): NEJ039A Ko, R.; Mouri, A.; Kisohara, A.; Morita, R.; Nakagawa, T.; Makiguchi, T.; Isobe, K.; Ishikawa, N.; Kondo, T.; Akiyama, M.; Bessho, A.; Honda, R.; Yoshimura, K.; Kagamu, H.; Kato, S.; Kobayashi, K.; Kaira, K. 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
.png){kind=icon}
分享.png){kind=icon}
收藏
